Geneos Wealth Management Inc. Sarepta Therapeutics, Inc. Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 16 shares of SRPT stock, worth $1,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,857% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
83.9MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.04 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$727 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$506 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$496 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.2B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...